Company profile

Therapanacea Sas

Therapanacea Sas has 4 AI-enabled medical devices on the FDA list. The first decision was on April 19, 2023 and the most recent on December 23, 2025 (ART-Plan+ (v3.1.0)). Its most common review panel is Radiology (4 devices).

4AI devices
2023First decision
2025Latest decision
1Specialties

Per year

2023: 12024: 12025: 2
202320242025
Therapanacea Sas AI devices per year: 2023 1, 2024 1, 2025 2

By specialty

  • Radiology4

Related guides

Timeline

  1. ART-Plan+ (v3.1.0) · Radiology · MUJ
  2. ART-Plan+ (v.3.0.0) · Radiology · MUJ
  3. ART-Plan (v.2.2.0) · Radiology · MUJ
  4. ART-Plan · Radiology · QKB